Counters
Mostrando 13-24 de 53 artigos, teses e dissertações.
-
13. Otimização de desempenho utilizando contadores de hardware / Performanceoptimizationusinghardwarecounters
A disponibilidade de microcomputadores cada vez mais potentes, com capacidade computacional e área de armazenamento próximos da capacidade de estações de trabalho caríssimas, tem colocado a comunidade científica diante de uma nova ferramenta para o desenvolvimento de aplicações científicas. A utilização dessas novas plataformas no meio científico
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 19/06/2000
-
14. Performanceoptimizationusinghardwarecounters / Otimização de desempenho utilizando contadores de hardware
A disponibilidade de microcomputadores cada vez mais potentes, com capacidade computacional e área de armazenamento próximos da capacidade de estações de trabalho caríssimas, tem colocado a comunidade científica diante de uma nova ferramenta para o desenvolvimento de aplicações científicas. A utilização dessas novas plataformas no meio científico
Publicado em: 2000
-
15. Otimização de desempenho utilizando contadores de hardware / Performanceoptimizationusinghardwarecounters
A disponibilidade de microcomputadores cada vez mais potentes, com capacidade computacional e área de armazenamento próximos da capacidade de estações de trabalho caríssimas, tem colocado a comunidade científica diante de uma nova ferramenta para o desenvolvimento de aplicações científicas. A utilização dessas novas plataformas no meio científico
Publicado em: 2000
-
16. Monocyte counting: discrepancies in results obtained with different automated instruments.
To determine the accuracy of several methods for measuring the monocyte count, the results obtained by a number of different automated cell counters were analysed. Considerable discrepancies occurred for monocyte counts obtained in normal blood among the counters. The results of a visual monocyte count on a total of 800 leucocytes were used as the reference
-
17. Automatic platelet counters.
-
18. Interface for Coulter S counters.
-
19. Comparison of Benchtop Microplate Beta Counters with the Traditional Gamma Counting Method for Measurement of Chromium-51 Release in Cytotoxic Assays
The most traditional method used to measure the lytic activity of cytotoxic T lymphocytes or natural killer (NK) cells is the chromium release assay (CRA). No study has been reported that systematically compares the traditional gamma counting method with various benchtop microplate scintillation formats to measure chromium release. Here we investigated the u
American Society for Microbiology.
-
20. Minister counters royal college claims about NHS allergy services
BMJ Publishing Group Ltd..
-
21. Measurement of haematological indices of chronic rheumatic disease with two newer generation automated systems, the H1 and H6000 (Technicon).
Two automated counters, the H1 (Technicon) and the H6000 (Technicon), which count 10,000 cells per sample, were compared and used to examine the clinical relevance of the additional haematological information now provided to the rheumatologist in three groups of patients--38 with rheumatoid arthritis (RA), 41 with ankylosing spondylitis (AS), and 35 with sys
-
22. Differential Counting in Mixed Cultures with Coulter Counters
A critical comparison of Coulter, viable, and microscope counts for several mixed cultures of microorganisms has been made. This investigation shows that Coulter counting can provide reliable estimates of microbial numbers in mixed cultures. Precautions and limitations of Coulter counting in mixed cultures are discussed.
-
23. Should terminally ill patients have the right to take drugs that pass phase I testing? Yes
The United States is considering allowing experimental drugs to be given to people at the end of life. Emil J Freireich believes patients should be able to judge the risks for themselves, and Dean Gesme counters that use of such drugs outside trials will damage both individuals and science
BMJ Publishing Group Ltd..
-
24. Should terminally ill patients have the right to take drugs that pass phase I testing? No
The United States is considering allowing experimental drugs to be given to people at the end of life. Emil J Freireich believes patients should be able to judge the risks for themselves, and Dean Gesme counters that use o such drugs outside trials will damage both individuals and science
BMJ Publishing Group Ltd..